Epilepsy News Listing

Community Corner
Sat, 06/10/2017
Recently we shared results of a trial of Epidiolex (a form of purified cannabidiol or CBD) in people with Dravet syndrome. We hear about cannabis in the news all the time too. Many questions, excitement, and skepticism are arising amongst our...
Survey
Tue, 06/06/2017
FasterCures is conducting a project to break down health data so patients and caregivers can have a better understanding of how it is collected, shared, and used. FasterCures is a nonprofit organization and a center of the Milken Institute that...
Wed, 05/31/2017
Neurostimulation (using devices to treat epilepsy) is an acceptable way of treating seizures in people with refractory epilepsy. It’s usually considered in people who are not appropriate for epilepsy surgery or when surgery is not helpful. With...
Wed, 05/31/2017
Recently, the New England Journal of Medicine (NEJM)1 published the results of a Phase 3 study of a purified cannabidiol (CBD) medication, called Epidiolex, in Dravet syndrome. The process used in this study is considered the “gold standard” method...
Wed, 05/31/2017
Landover, Maryland - The Epilepsy Foundation announced the winners of the 2017 Shark Tank competition for innovative ideas in epilepsy and seizure treatment and care on May 18, 2017, at the Antiepileptic Drug and Device (AEDD) Trials XIV Conference...

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline